Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Annette Raskov Kodahl

7PUBLICATIONS

27CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Dec 04, 2025

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial.

Odd Lilleng Gammelgaard, Sidse Ehmsen, Anne Marie Bak Jylling

|Apr 22, 2025

Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo.

Signe Borgquist, Maj-Britt Jensen, Cecilie Linea Bendorff

|Mar 28, 2024

Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer.

Anne-Dorthe Mosgaard Knudsen, Mikala Wej Modvig, Marianne Vogsen

|Jan 06, 2024

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.

Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin

|Oct 28, 2022

Management and outcomes after neoadjuvant treatment for locally advanced breast cancer in older <i>versus</i> younger women.

Caroline Wium Hansen, Marianne Vogsen, Annette Raskov Kodahl

|Jan 11, 2022

Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT.

Mohammad Naghavi-Behzad, Marianne Vogsen, Rasmus Mølgård Vester

Pageof 2

Frequent Collaborators

3 joint publications

Marianne Vogsen

2 joint publications

Odd Lilleng Gammelgaard

2 joint publications

Henrik J Ditzel

1 joint publications

S Ehmsen

1 joint publications

N Aggerholm-Pedersen

1 joint publications

A Glenthøj

1 joint publications

J Ryg

1 joint publications

H Frederiksen

1 joint publications

Bent Ejlertsen

1 joint publications

Simone Johansen

Frequent Collaborators

3 joint publications

Marianne Vogsen

2 joint publications

Odd Lilleng Gammelgaard

2 joint publications

Henrik J Ditzel

1 joint publications

S Ehmsen

Top Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on : Mar 20, 2020

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos

Top Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on : Mar 20, 2020

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos